Stephen A Barrand, MD | |
85 Herrick Street, Radiology Department, Beverly, MA 01915-1790 | |
(978) 922-3000 | |
Not Available |
Full Name | Stephen A Barrand |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 38 Years |
Location | 85 Herrick Street, Beverly, Massachusetts |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538155171 | NPI | - | NPPES |
3077179 | Medicaid | MA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 72148 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Northeast Hospital Corporation | Beverly, MA | Hospital |
Lahey Hospital & Medical Center, Burlington | Burlington, MA | Hospital |
Winchester Hospital | Winchester, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Beverly Radiology Associates Inc | 0345241154 | 21 |
News Archive
The pain from hammertoe, a deformity that can cause one or more toes to assume a claw shape, can curtail an evening of dancing or make a favorite pair of shoes unwearable. But, according to the June issue of Mayo Clinic Health Letter, this condition often can be managed by proper footwear or simple toe coverings.
Scientists at the Centro Nacional de Investigaciones Cardiovasculares and the Centro de Investigaciones Biológicas of the Consejo Superior de Investigaciones Científicas have identified the protease MT1-MMP as a possible future target for drugs to treat inflammatory bowel disease.
Net Enforcers, one of the nation's leading providers of online channel intelligence and brand protection services, announced today the release of a new version of its Web-based client portal designed to help sales and marketing executives analyze detailed information on how their products and brands are marketed by online dealers.
Esperance Pharmaceuticals Inc. today announced that it has entered into a strategic alliance agreement with MD Anderson Cancer Center to accelerate the clinical development of its lead anti-cancer candidate EP-100 for the treatment of ovarian cancer and to collaborate on preclinical studies of EP-100 as a treatment for breast cancer.
ZIOPHARM Oncology, Inc., a biopharmaceutical company that is seeking to develop and commercialize a diverse, risk sensitive portfolio of in-licensed cancer drugs addressing unmet medical needs, announced today its financial results for the fourth quarter and full year 2009, and the filing of its Annual Report on Form 10-K with the Securities and Exchange Commission.
› Verified 9 days ago
Entity Name | Beverly Radiology Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538110846 PECOS PAC ID: 0345241154 Enrollment ID: O20070122000586 |
News Archive
The pain from hammertoe, a deformity that can cause one or more toes to assume a claw shape, can curtail an evening of dancing or make a favorite pair of shoes unwearable. But, according to the June issue of Mayo Clinic Health Letter, this condition often can be managed by proper footwear or simple toe coverings.
Scientists at the Centro Nacional de Investigaciones Cardiovasculares and the Centro de Investigaciones Biológicas of the Consejo Superior de Investigaciones Científicas have identified the protease MT1-MMP as a possible future target for drugs to treat inflammatory bowel disease.
Net Enforcers, one of the nation's leading providers of online channel intelligence and brand protection services, announced today the release of a new version of its Web-based client portal designed to help sales and marketing executives analyze detailed information on how their products and brands are marketed by online dealers.
Esperance Pharmaceuticals Inc. today announced that it has entered into a strategic alliance agreement with MD Anderson Cancer Center to accelerate the clinical development of its lead anti-cancer candidate EP-100 for the treatment of ovarian cancer and to collaborate on preclinical studies of EP-100 as a treatment for breast cancer.
ZIOPHARM Oncology, Inc., a biopharmaceutical company that is seeking to develop and commercialize a diverse, risk sensitive portfolio of in-licensed cancer drugs addressing unmet medical needs, announced today its financial results for the fourth quarter and full year 2009, and the filing of its Annual Report on Form 10-K with the Securities and Exchange Commission.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Stephen A Barrand, MD 2527 Cranberry Highway, Attn: Nanci Kardos-carll/provider Relations Dept., Wareham, MA 02571-1046 Ph: (800) 841-5200 | Stephen A Barrand, MD 85 Herrick Street, Radiology Department, Beverly, MA 01915-1790 Ph: (978) 922-3000 |
News Archive
The pain from hammertoe, a deformity that can cause one or more toes to assume a claw shape, can curtail an evening of dancing or make a favorite pair of shoes unwearable. But, according to the June issue of Mayo Clinic Health Letter, this condition often can be managed by proper footwear or simple toe coverings.
Scientists at the Centro Nacional de Investigaciones Cardiovasculares and the Centro de Investigaciones Biológicas of the Consejo Superior de Investigaciones Científicas have identified the protease MT1-MMP as a possible future target for drugs to treat inflammatory bowel disease.
Net Enforcers, one of the nation's leading providers of online channel intelligence and brand protection services, announced today the release of a new version of its Web-based client portal designed to help sales and marketing executives analyze detailed information on how their products and brands are marketed by online dealers.
Esperance Pharmaceuticals Inc. today announced that it has entered into a strategic alliance agreement with MD Anderson Cancer Center to accelerate the clinical development of its lead anti-cancer candidate EP-100 for the treatment of ovarian cancer and to collaborate on preclinical studies of EP-100 as a treatment for breast cancer.
ZIOPHARM Oncology, Inc., a biopharmaceutical company that is seeking to develop and commercialize a diverse, risk sensitive portfolio of in-licensed cancer drugs addressing unmet medical needs, announced today its financial results for the fourth quarter and full year 2009, and the filing of its Annual Report on Form 10-K with the Securities and Exchange Commission.
› Verified 9 days ago
Peter Curatolo, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 85 Herrick Street, Radiology Department, Beverly, MA 01915 Phone: 978-922-3000 | |
Dr. Mary Jane O'neill, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 85 Herrick St, C/o Sharon Hayes, Radiology Dept, Beverly, MA 01915 Phone: 978-922-3000 Fax: 978-921-7011 | |
Augustine P O'keeffe, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 85 Herrick St, Radiology Department, Beverly, MA 01915 Phone: 978-927-6385 Fax: 978-921-7011 | |
Dr. John Hallock Oldershaw, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 85 Herrick St, Beverly, MA 01915 Phone: 978-922-3000 | |
Christopher Curran Bolus, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 85 Herrick St, Beverly, MA 01915 Phone: 978-922-3000 Fax: 978-921-7011 | |
Lindsay F Pearce, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 85 Herrick Street, Radiology Department, Beverly, MA 01915 Phone: 978-922-3000 | |
Evan L Rochman, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 85 Herrick St, Radiology Department, Beverly, MA 01915 Phone: 978-927-6385 Fax: 978-921-7011 |